Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Fucoidan/VEGF-based surface modification of decellularized pulmonary heart valve improves the antithrombotic and re-endothelialization potential of bioprostheses.

Marinval N, Morenc M, Labour MN, Samotus A, Mzyk A, Ollivier V, Maire M, Jesse K, Bassand K, Niemiec-Cyganek A, Haddad O, Jacob MP, Chaubet F, Charnaux N, Wilczek P, Hlawaty H.

Biomaterials. 2018 Jul;172:14-29. doi: 10.1016/j.biomaterials.2018.01.054. Epub 2018 Mar 16.

PMID:
29715592
2.

Pro-angiogenic effect of RANTES-loaded polysaccharide-based microparticles for a mouse ischemia therapy.

Suffee N, Le Visage C, Hlawaty H, Aid-Launais R, Vanneaux V, Larghero J, Haddad O, Oudar O, Charnaux N, Sutton A.

Sci Rep. 2017 Oct 16;7(1):13294. doi: 10.1038/s41598-017-13444-7.

3.

Identification of a Pro-Angiogenic Potential and Cellular Uptake Mechanism of a LMW Highly Sulfated Fraction of Fucoidan from Ascophyllum nodosum.

Marinval N, Saboural P, Haddad O, Maire M, Bassand K, Geinguenaud F, Djaker N, Ben Akrout K, Lamy de la Chapelle M, Robert R, Oudar O, Guyot E, Laguillier-Morizot C, Sutton A, Chauvierre C, Chaubet F, Charnaux N, Hlawaty H.

Mar Drugs. 2016 Oct 17;14(10). pii: E185.

4.

Heparanase and Syndecan-4 Are Involved in Low Molecular Weight Fucoidan-Induced Angiogenesis.

Haddad O, Guyot E, Marinval N, Chevalier F, Maillard L, Gadi L, Laguillier-Morizot C, Oudar O, Sutton A, Charnaux N, Hlawaty H.

Mar Drugs. 2015 Oct 28;13(11):6588-608. doi: 10.3390/md13116588.

5.

Targeting VEGF-A with a vaccine decreases inflammation and joint destruction in experimental arthritis.

Semerano L, Duvallet E, Belmellat N, Marival N, Schall N, Monteil M, Grouard-Vogel G, Bernier E, Lecouvey M, Hlawaty H, Muller S, Boissier MC, Assier E.

Angiogenesis. 2016 Jan;19(1):39-52. doi: 10.1007/s10456-015-9487-0. Epub 2015 Sep 29.

PMID:
26419779
6.

A fine structural modification of glycosaminoglycans is correlated with the progression of muscle regeneration after ischaemia: towards a matrix-based therapy?

Chevalier F, Arnaud D, Henault E, Guillevic O, Siñeriz F, Ponsen AC, Papy-Garcia D, Barritault D, Letourneur D, Uzan G, Meddahi-Pellé A, Hlawaty H, Albanese P.

Eur Cell Mater. 2015 Sep 4;30:51-68.

7.

miR-126 Is Involved in Vascular Remodeling under Laminar Shear Stress.

Mondadori dos Santos A, Metzinger L, Haddad O, M'baya-Moutoula E, Taïbi F, Charnaux N, Massy ZA, Hlawaty H, Metzinger-Le Meuth V.

Biomed Res Int. 2015;2015:497280. doi: 10.1155/2015/497280. Epub 2015 Jun 28.

8.

The leukotriene B4 receptor (BLT) antagonist BIIL284 decreases atherosclerosis in ApoE-/- mice.

Ketelhuth DF, Hermansson A, Hlawaty H, Letourneur D, Yan ZQ, Bäck M.

Prostaglandins Other Lipid Mediat. 2015 Sep;121(Pt A):105-9. doi: 10.1016/j.prostaglandins.2015.05.007. Epub 2015 Jun 4.

PMID:
26051858
9.

Fucoidan in a 3D scaffold interacts with vascular endothelial growth factor and promotes neovascularization in mice.

Purnama A, Aid-Launais R, Haddad O, Maire M, Mantovani D, Letourneur D, Hlawaty H, Le Visage C.

Drug Deliv Transl Res. 2015 Apr;5(2):187-97. doi: 10.1007/s13346-013-0177-4.

PMID:
25787743
10.

Comparative toxicity evaluation of flower-shaped and spherical gold nanoparticles on human endothelial cells.

Sultana S, Djaker N, Boca-Farcau S, Salerno M, Charnaux N, Astilean S, Hlawaty H, de la Chapelle ML.

Nanotechnology. 2015 Feb 6;26(5):055101. doi: 10.1088/0957-4484/26/5/055101. Epub 2015 Jan 9.

PMID:
25573907
11.

Dynamic contact angle analysis of protein adsorption on polysaccharide multilayer's films for biomaterial reendothelialization.

Benni S, Avramoglou T, Hlawaty H, Mora L.

Biomed Res Int. 2014;2014:679031. doi: 10.1155/2014/679031. Epub 2014 Sep 8.

12.

RANTES/CCL5 mediated-biological effects depend on the syndecan-4/PKCα signaling pathway.

Maillard L, Saito N, Hlawaty H, Friand V, Suffee N, Chmilewsky F, Haddad O, Laguillier C, Guyot E, Ueyama T, Oudar O, Sutton A, Charnaux N.

Biol Open. 2014 Sep 26;3(10):995-1004. doi: 10.1242/bio.20148227.

13.

RANTES/CCL5-induced pro-angiogenic effects depend on CCR1, CCR5 and glycosaminoglycans.

Suffee N, Hlawaty H, Meddahi-Pelle A, Maillard L, Louedec L, Haddad O, Martin L, Laguillier C, Richard B, Oudar O, Letourneur D, Charnaux N, Sutton A.

Angiogenesis. 2012 Dec;15(4):727-44. doi: 10.1007/s10456-012-9285-x. Epub 2012 Jun 30.

PMID:
22752444
14.

Angiogenic properties of the chemokine RANTES/CCL5.

Suffee N, Richard B, Hlawaty H, Oudar O, Charnaux N, Sutton A.

Biochem Soc Trans. 2011 Dec;39(6):1649-53. doi: 10.1042/BST20110651. Review.

PMID:
22103502
15.

Low molecular weight fucoidan prevents intimal hyperplasia in rat injured thoracic aorta through the modulation of matrix metalloproteinase-2 expression.

Hlawaty H, Suffee N, Sutton A, Oudar O, Haddad O, Ollivier V, Laguillier-Morizot C, Gattegno L, Letourneur D, Charnaux N.

Biochem Pharmacol. 2011 Jan 15;81(2):233-43. doi: 10.1016/j.bcp.2010.09.021. Epub 2010 Sep 29.

PMID:
20887714
16.

Development of a functionalized polymer for stent coating in the arterial delivery of small interfering RNA.

San Juan A, Bala M, Hlawaty H, Portes P, Vranckx R, Feldman LJ, Letourneur D.

Biomacromolecules. 2009 Nov 9;10(11):3074-80. doi: 10.1021/bm900740g.

PMID:
19761207
17.

Glycosaminoglycan mimetics inhibit SDF-1/CXCL12-mediated migration and invasion of human hepatoma cells.

Friand V, Haddad O, Papy-Garcia D, Hlawaty H, Vassy R, Hamma-Kourbali Y, Perret GY, Courty J, Baleux F, Oudar O, Gattegno L, Sutton A, Charnaux N.

Glycobiology. 2009 Dec;19(12):1511-24. doi: 10.1093/glycob/cwp130. Epub 2009 Aug 28.

PMID:
19717493
18.

Monocyte chemoattractant protein-1 (MCP-1)/CCL2 secreted by hepatic myofibroblasts promotes migration and invasion of human hepatoma cells.

Dagouassat M, Suffee N, Hlawaty H, Haddad O, Charni F, Laguillier C, Vassy R, Martin L, Schischmanoff PO, Gattegno L, Oudar O, Sutton A, Charnaux N.

Int J Cancer. 2010 Mar 1;126(5):1095-108. doi: 10.1002/ijc.24800.

19.

Syndecan-1 and syndecan-4 are involved in RANTES/CCL5-induced migration and invasion of human hepatoma cells.

Charni F, Friand V, Haddad O, Hlawaty H, Martin L, Vassy R, Oudar O, Gattegno L, Charnaux N, Sutton A.

Biochim Biophys Acta. 2009 Oct;1790(10):1314-26. doi: 10.1016/j.bbagen.2009.07.015. Epub 2009 Jul 24.

PMID:
19632304
20.

Leukotriene receptor antagonism and the prevention of extracellular matrix degradation during atherosclerosis and in-stent stenosis.

Hlawaty H, Jacob MP, Louedec L, Letourneur D, Brink C, Michel JB, Feldman L, Bäck M.

Arterioscler Thromb Vasc Biol. 2009 Apr;29(4):518-24. doi: 10.1161/ATVBAHA.108.181750. Epub 2009 Jan 22.

PMID:
19164806
21.

Local matrix metalloproteinase 2 gene knockdown in balloon-injured rabbit carotid arteries using nonviral-small interfering RNA transfection.

Hlawaty H, San Juan A, Jacob MP, Vranckx R, Letourneur D, Feldman LJ.

J Gene Med. 2009 Jan;11(1):92-9. doi: 10.1002/jgm.1275.

PMID:
19040207
22.

The oral cavity and age: a site of chronic inflammation?

Bäck M, Hlawaty H, Labat C, Michel JB, Brink C.

PLoS One. 2007 Dec 26;2(12):e1351.

23.

Inhibition of MMP-2 gene expression with small interfering RNA in rabbit vascular smooth muscle cells.

Hlawaty H, San Juan A, Jacob MP, Vranckx R, Letourneur D, Feldman LJ.

Am J Physiol Heart Circ Physiol. 2007 Dec;293(6):H3593-601. Epub 2007 Sep 21.

24.

Tubular cationized pullulan hydrogels as local reservoirs for plasmid DNA.

San Juan A, Ducrocq G, Hlawaty H, Bataille I, Guénin E, Letourneur D, Feldman LJ.

J Biomed Mater Res A. 2007 Dec 1;83(3):819-27.

PMID:
17559120
25.

Cationized pullulan 3D matrices as new materials for gene transfer.

San Juan A, Hlawaty H, Chaubet F, Letourneur D, Feldman LJ.

J Biomed Mater Res A. 2007 Aug;82(2):354-62.

PMID:
17295225

Supplemental Content

Loading ...
Support Center